Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA PFIZER BAL PHARMA/
PFIZER
 
P/E (TTM) x 41.0 38.4 106.9% View Chart
P/BV x 2.3 6.0 37.8% View Chart
Dividend Yield % 1.1 1.7 65.6%  

Financials

 BAL PHARMA   PFIZER
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
PFIZER
Mar-23
BAL PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1344,662 2.9%   
Low Rs633,407 1.9%   
Sales per share (Unadj.) Rs193.9530.0 36.6%  
Earnings per share (Unadj.) Rs1.7136.4 1.2%  
Cash flow per share (Unadj.) Rs7.5159.4 4.7%  
Dividends per share (Unadj.) Rs1.0070.00 1.4%  
Avg Dividend yield %1.01.7 58.4%  
Book value per share (Unadj.) Rs40.7701.0 5.8%  
Shares outstanding (eoy) m15.6945.75 34.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.57.6 6.7%   
Avg P/E ratio x59.229.6 200.0%  
P/CF ratio (eoy) x13.225.3 52.1%  
Price / Book Value ratio x2.45.8 42.2%  
Dividend payout %59.951.3 116.7%   
Avg Mkt Cap Rs m1,549184,576 0.8%   
No. of employees `000NANA-   
Total wages/salary Rs m5533,317 16.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,04224,248 12.5%  
Other income Rs m91,011 0.9%   
Total revenues Rs m3,05225,258 12.1%   
Gross profit Rs m2538,420 3.0%  
Depreciation Rs m911,055 8.7%   
Interest Rs m123135 91.4%   
Profit before tax Rs m478,240 0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m212,001 1.1%   
Profit after tax Rs m266,239 0.4%  
Gross profit margin %8.334.7 23.9%  
Effective tax rate %44.824.3 184.7%   
Net profit margin %0.925.7 3.3%  
BALANCE SHEET DATA
Current assets Rs m2,28224,933 9.2%   
Current liabilities Rs m2,0936,574 31.8%   
Net working cap to sales %6.275.7 8.2%  
Current ratio x1.13.8 28.7%  
Inventory Days Days893 8.2%  
Debtors Days Days1,1282 49,366.5%  
Net fixed assets Rs m82913,780 6.0%   
Share capital Rs m157458 34.3%   
"Free" reserves Rs m48131,616 1.5%   
Net worth Rs m63832,073 2.0%   
Long term debt Rs m3050-   
Total assets Rs m3,11039,031 8.0%  
Interest coverage x1.462.1 2.2%   
Debt to equity ratio x0.50-  
Sales to assets ratio x1.00.6 157.5%   
Return on assets %4.816.3 29.4%  
Return on equity %4.119.5 21.1%  
Return on capital %18.126.1 69.3%  
Exports to sales %66.42.8 2,341.3%   
Imports to sales %22.40 64,764.1%   
Exports (fob) Rs m2,020688 293.7%   
Imports (cif) Rs m6838 8,125.5%   
Fx inflow Rs m2,020688 293.7%   
Fx outflow Rs m7168 8,521.0%   
Net fx Rs m1,305679 192.0%   
CASH FLOW
From Operations Rs m-183,557 -0.5%  
From Investments Rs m-222-361 61.5%  
From Financial Activity Rs m244-3,458 -7.1%  
Net Cashflow Rs m4-262 -1.4%  

Share Holding

Indian Promoters % 47.1 0.0 -  
Foreign collaborators % 4.2 63.9 6.5%  
Indian inst/Mut Fund % 0.1 18.2 0.7%  
FIIs % 0.1 3.0 4.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 36.1 135.2%  
Shareholders   15,060 112,456 13.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs Pfizer Share Price Performance

Period BAL PHARMA Pfizer S&P BSE HEALTHCARE
1-Day -3.93% -4.34% 1.13%
1-Month -17.35% -7.79% -0.80%
1-Year 41.62% 22.38% 61.74%
3-Year CAGR 19.23% -1.91% 18.14%
5-Year CAGR 5.53% 5.05% 19.77%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.